Intermittent Fasting8 min readUpdated October 29, 2026

Time-Restricted Eating and the Brain: What the First Huntington’s Disease Pilot Does (and Doesn’t) Mean for Everyone Else

A 20-person pilot found an eight-hour eating window was feasible in early Huntington’s disease, with stable weight and small improvements in two disease markers. It had no control group.

Time-Restricted Eating and the Brain: What the First Huntington’s Disease Pilot Does and Doesn’t Mean — MacrosMeasure
Time-Restricted Eating and the Brain: What the First Huntington’s Disease Pilot Does and Doesn’t Mean — MacrosMeasure
D
Dr. Aisha, RD
Registered Dietitian & Sports Nutritionist, MS

In this guide

  1. Why a Huntington's pilot is in a fasting guide

  2. The OHSU pilot at a glance

  3. Why researchers tried time-restricted eating in Huntington's

  4. What they found

  5. How to read cUHDRS and neurofilament light

  6. What a single-arm pilot cannot show

  7. The reassuring part: weight and lean mass held steady

  8. What it means for people without Huntington's

  9. Six questions for reading any pilot study

  10. If you or a family member is affected

  11. The bottom line

  12. Frequently asked questions

Most fasting research asks about weight, blood sugar or appetite. A September paper in Nature Metabolism asked something different and more serious: can changing when people with early Huntington's disease eat help slow the disease itself? The headlines were hopeful, with phrases like "a simple change in when you eat". The study is real, careful and small, and it deserves a close read, partly for what it shows and partly because it's a great case study in how to interpret pilot trials.

We read the journal summary, the university's news release and the trial registration. This article isn't medical advice, and if you or someone you love is affected by Huntington's disease, please talk to a neurologist before changing eating patterns.

The short version: in a 12-week, open-label, single-arm pilot of 20 adults with early-stage Huntington's disease, an eight-hour eating window was feasible (participants stayed inside it on roughly 76 of 84 days), weight and fat-free mass stayed stable, a composite disease-progression score improved by about 0.5 points, and a blood marker of nerve-cell damage (neurofilament light) fell. With no comparison group, the study can't show that time-restricted eating slowed the disease. It can show that the approach is safe enough and promising enough to test properly.

Why a Huntington's Pilot Is in a Fasting Guide

Two reasons. First, it's a good test of whether time-restricted eating (TRE) can be done safely in people at risk of unintentional weight loss, which is a common problem in Huntington's and in many ageing and neurological conditions. Second, it's one of many headlines where a small pilot gets read as a big result, and understanding the gap helps with every "fasting cures X" claim you'll see.

The OHSU Pilot at a Glance

ItemDetails
TitleEffects of time-restricted eating in early-stage Huntington's disease: a pilot study
Journal and dateNature Metabolism, 17 September 2026; Oregon Health & Science University (lead author Russell Wells, with senior investigators)
RegistrationClinicalTrials.gov NCT06490367
Participants20 adults with early-stage Huntington's disease (10 women, 10 men)
DesignOpen-label, single-arm, 12 weeks; no control group
InterventionEat within a self-selected window of about 8 hours, with fasting outside it; most chose later windows starting around mid-morning
AdherenceInside the window on average about 75.6 of 84 days
Weight and body compositionBody weight and fat-free mass stable
Disease measuresComposite Unified Huntington's Disease Rating Scale (cUHDRS) improved by about 0.5 points; plasma neurofilament light (NfL) decreased

Why Researchers Tried Time-Restricted Eating in Huntington's

Huntington's disease is an inherited neurodegenerative condition caused by a genetic expansion in the HTT gene. It causes movement problems, cognitive and mood changes, and progressive decline, and treatments mostly manage symptoms while trials of disease-modifying therapies continue. Beyond the brain, the disease also disrupts energy metabolism and circadian rhythms: many people lose weight despite eating normally, and sleep and body-clock regularity are often disturbed.

Those features made TRE an attractive idea. Eating within a consistent daily window acts as a timing cue for the body clock, and may help cellular energy handling. In earlier work on Huntington's mouse models, time-restricted feeding improved circadian rhythms and some motor measures. The OHSU pilot was the first step toward asking whether something similar might help people.

What They Found

  • It was feasible. Participants stayed within their eight-hour window on average about 76 of 84 days, roughly 90% adherence, in a population where cognition and daily routines can be challenging.
  • Weight and lean mass held. There was no significant loss of body weight or fat-free mass, which matters in a disease associated with weight loss.
  • The progression score improved. The cUHDRS rose by about 0.5 points on average over 12 weeks.
  • A damage marker fell. Plasma neurofilament light, a protein released into the blood when nerve cells are injured, decreased.

The authors and the university describe the results as promising and as grounds for a randomised trial, not as proof that TRE slows Huntington's. Lead author Russell Wells emphasised that showing a real effect on the disease will require a controlled trial.

How to Read cUHDRS and Neurofilament Light

MeasureWhat it isCaution
cUHDRSA composite score combining motor, cognitive and functional assessments, widely used to track Huntington's progressionSmall changes can reflect practice effects on cognitive tests, day-to-day variation, or expectations when participants know they're receiving a treatment
Neurofilament light (NfL)A protein from nerve fibres that rises in the blood when neurons are damaged; used as a biomarker across neurodegenerative diseasesIt fluctuates and can change with age, kidney function and other factors; a drop is encouraging but not proof of a slower disease

A 0.5-point change in a composite score is small, and the study can't tell us whether it's clinically meaningful for a person's daily life. Both markers are useful signals to follow up, which is exactly how the authors treat them.

What a Single-Arm Pilot Cannot Show

  • No comparison group. Without people continuing normal eating, we can't know how many would have improved, stayed flat or declined over 12 weeks anyway.
  • Open-label. Participants and investigators knew everyone was on TRE, so expectation can influence cognitive tests, mood and even sleep.
  • Practice effects. Repeating cognitive and motor tests often improves scores simply from familiarity.
  • Twenty people. The results could shift substantially with a different or larger group.
  • Twelve weeks is short. Huntington's progresses over years, so a short change doesn't establish a slowed disease course.
  • Early-stage only. Results may not apply to later stages, when eating, swallowing and weight loss become harder.

The Reassuring Part: Weight and Lean Mass Held Steady

One of the most practical findings is also the least dramatic. Participants didn't lose weight or fat-free mass on an eight-hour window. That's relevant well beyond Huntington's. A common worry about fasting is that it will cost muscle, especially in people who are older or unwell. This pilot suggests that, with attention to eating enough, a compressed window doesn't have to do that.

That said, it shouldn't be over-read. We don't know how closely calories and protein were managed, the group was small, and Huntington's has its own metabolic quirks. For general readers, the safest lesson is that protein and total energy matter more than the clock, as we discuss in our guides to protein targets and meal spacing.

What It Means for People Without Huntington's

Honestly, not much, and that's an important point. The study doesn't show that fasting protects healthy brains, prevents dementia or slows ageing. It's a pilot in a specific disease, with disease-specific markers. A few modest takeaways do apply:

  • TRE can be feasible and safe in vulnerable groups when it's supervised and weight is monitored.
  • Circadian regularity may matter. The rationale for TRE, a consistent daily rhythm, is an interesting thread that other trials are testing in healthy older adults.
  • Hype outruns evidence. A hopeful pilot doesn't mean you should rearrange your eating to protect your brain. Our daily calories guide and TDEE calculator are better starting points for most people.

Six Questions for Reading Any Pilot Study

Ask…Why it matters
Was there a control group?Without one, improvement could be time, practice or placebo
Was it randomised and blinded?Randomisation balances groups; blinding limits expectation effects
How many people?Small samples swing; look for replication
What outcomes?Biomarkers and scores aren't the same as how people feel and function
How long?Chronic disease needs long follow-up
Who's it for?A disease-specific result rarely transfers to healthy people

If You or a Family Member Is Affected

  • Talk to the neurology team first. Don't start a fasting pattern on your own, especially if weight loss, swallowing difficulty or falls are concerns.
  • Prioritise adequate calories and protein. Huntington's often raises energy needs, and a dietitian can help set targets.
  • Watch medications and blood sugar. If you have diabetes or take medicines with food, timing changes need medical input.
  • Consider enrolling in a trial. A randomised study of TRE is the right next step; ask your clinic or a Huntington's research network about opportunities.

The Bottom Line

The OHSU pilot shows that an eight-hour eating window was feasible, kept weight and lean mass stable and was followed by small improvements in a progression score and a nerve-damage marker in 20 people with early Huntington's disease. It's a hopeful first step and a good reason to run a randomised trial.

It isn't evidence that fasting slows Huntington's or protects the brain in general. The honest reading, and the one the authors themselves give, is cautious optimism. For the rest of us, the best use of this study is as a reminder to ask whether a result has a control group, enough people and the right outcomes before we change how we eat.

Frequently Asked Questions

Can intermittent fasting slow Huntington's disease?

A small 12-week pilot found that time-restricted eating was feasible and was followed by small improvements in a progression score and a nerve-damage marker, but with no control group it can't show that it slows the disease. A randomised trial is needed.

How many people were in the study?

Twenty adults with early-stage Huntington's disease took part in the analysis, ten women and ten men.

What eating window did participants use?

About eight hours a day, with fasting outside the window. Participants chose their own timing, and most selected later windows beginning around mid-morning.

Did participants lose weight or muscle?

No significant loss of body weight or fat-free mass was reported, which matters because weight loss is common in Huntington's disease.

What is neurofilament light?

A protein released from damaged nerve fibres that can be measured in the blood. It's used as a biomarker in several neurodegenerative diseases. In the pilot it decreased, which is encouraging but not proof of a slower disease course.

Does this mean fasting protects the brain in healthy people?

No. The study was done in people with early Huntington's disease and didn't test healthy adults. Other trials are examining time-restricted eating and brain health in older adults, but results aren't available yet.

Should people with Huntington's try fasting?

Only with their neurology team's agreement. Weight loss, swallowing problems, falls and medication timing all need individual consideration, and the best next step is a controlled trial.


References & Sources

  1. Effects of time-restricted eating in early-stage Huntington's disease: a pilot study (2026). Nature Metabolism, published 17 September 2026. doi:10.1038/s42255-026-01612-x.
  2. Oregon Health & Science University news release (September 2026); Medical Xpress, Medscape and Huntington's Disease News coverage.
  3. Time-restricted eating in early-stage Huntington's disease: a 12-week interventional clinical trial protocol. PMC11936236; ClinicalTrials.gov NCT06490367.
  4. Whittaker, D. S. et al. (2018). Circadian-based treatment strategy effective in the BACHD mouse model of Huntington's disease. Journal of Biological Rhythms, 33(5), 535–554.
  5. MacrosMeasure (2026). Free TDEE Calculator.
Put it into practice

Calculate your own numbers — free.

18 science-backed calculators covering everything in this article and more.

⏱️ Fasting Timer 🔥 Calorie Calculator All 18 calculators
Fasting and Huntington’s: What the 2026 Pilot Really Shows